BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36317505)

  • 41. Xanthoma-like Skin Changes in an Elderly Woman with a Normal Lipid Profile.
    Nockowski P; Woźniak Z; Reich A; Maj J
    Acta Dermatovenerol Croat; 2017 Jul; 25(2):167-169. PubMed ID: 28871936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant interferon alfa-2b treatment of necrobiotic xanthogranuloma with paraproteinemia.
    Venencie PY; Le Bras P; Toan ND; Tchernia G; Delfraissy JF
    J Am Acad Dermatol; 1995 Apr; 32(4):666-7. PubMed ID: 7896960
    [No Abstract]   [Full Text] [Related]  

  • 43. Necrobiotic xanthogranuloma without a monoclonal gammopathy.
    Seastrom S; Bookout A; Hogan DJ
    Cutis; 2014 Dec; 94(6):293-6. PubMed ID: 25566570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Necrobiotic xanthogranuloma with paraproteinemia.
    Kossard S; Winkelmann RK
    J Am Acad Dermatol; 1980 Sep; 3(3):257-70. PubMed ID: 7451693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Necrobiotic xanthogranuloma with eye involvement. Overview and case report].
    Hohenleutner S; Hohenleutner U; Stolz W; Landthaler M
    Hautarzt; 1995 May; 46(5):330-4. PubMed ID: 7607896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A patient with necrobiotic xanthogranuloma presenting with an anterior mediastinal mass, plasma cell dyscrasia, and a lymphoproliferative disorder.
    Chen KY; Leslie W; Mahon B; Venugopal P
    Clin Adv Hematol Oncol; 2011 Sep; 9(9):696-700. PubMed ID: 22402515
    [No Abstract]   [Full Text] [Related]  

  • 47. Xenograft: a suitable treatment of eyelid complications in long-standing necrobiotic xanthogranuloma.
    Majtanova N; Kolar P; Takacova A; Kurilova V; Majtan J; Szep Z
    Clin Exp Dermatol; 2024 Feb; 49(3):280-282. PubMed ID: 37940107
    [No Abstract]   [Full Text] [Related]  

  • 48. Necrobiotic xanthogranuloma with myeloma. A case report.
    Venencie PY; Puissant A; Verola O; Kerneis Y; Marchat C; Le Bras P; D'Agay MF; Danon F; Valensi F; Turpin G
    Cancer; 1987 Feb; 59(3):588-92. PubMed ID: 3791168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Necrobiotic xanthogranuloma with paraproteinemia; an atypical case.
    Ito Y; Nishimura K; Yamanaka K; Hakamada A; Isoda K; Kurokawa I; Mizutani H
    J Dtsch Dermatol Ges; 2008 Jan; 6(1):40-3. PubMed ID: 17941882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapy of necrobiotic xanthogranuloma - case series and review of the literature.
    Hansen I; Ghandili S; Abeck F; Booken N; Schneider SW
    J Dtsch Dermatol Ges; 2023 Nov; 21(11):1315-1318. PubMed ID: 37811744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Necrobiotic xanthogranuloma.
    Rose A; Robinson M; Kamino H; Latkowski JA
    Dermatol Online J; 2012 Dec; 18(12):30. PubMed ID: 23286820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diffuse, ulcerating plaques and nodules. Necrobiotic xanthogranuloma (NXG) with paraproteinemia.
    Furner BB; Stevens CS
    Arch Dermatol; 1989 Feb; 125(2):287-8, 290. PubMed ID: 2913965
    [No Abstract]   [Full Text] [Related]  

  • 53. Management of Uveitis and Scleritis in Necrobiotic Xanthogranuloma.
    Gonzales JA; Haemel A; Gross AJ; Acharya NR
    J Ocul Pharmacol Ther; 2017 May; 33(4):325-333. PubMed ID: 28394239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Necrobiotic xanthogranuloma without monoclonal gammopathy and with a rapidly fatal outcome].
    Bernez A; Abdallah-Lotf M; D'Incan M; De Muret A; Souteyrand P; Lorette G; Machet L
    Ann Dermatol Venereol; 2006 Mar; 133(3):246-9. PubMed ID: 16800175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Necrobiotic xanthogranuloma associated with necrotizing scleritis.
    Peyman A; Walsh N; Green P; Dorey MW; Seamone C; Pasternak S
    Am J Dermatopathol; 2012 Aug; 34(6):644-7. PubMed ID: 22814320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria.
    Nelson CA; Zhong CS; Hashemi DA; Ashchyan HJ; Brown-Joel Z; Noe MH; Imadojemu S; Micheletti RG; Vleugels RA; Wanat KA; Rosenbach M; Mostaghimi A
    JAMA Dermatol; 2020 Mar; 156(3):270-279. PubMed ID: 31940000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adult Orbital Xanthogranulomatous Disease: A Review with Emphasis on Etiology, Systemic Associations, Diagnostic Tools, and Treatment.
    Kerstetter J; Wang J
    Dermatol Clin; 2015 Jul; 33(3):457-63. PubMed ID: 26143425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Necrobiotic xanthogranuloma with predominant periorbital involvement.
    Oestreicher J; Dookeran R; Nijhawan N; Kolin A
    Ophthalmic Plast Reconstr Surg; 2010; 26(6):473-5. PubMed ID: 21099384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of necrobiotic xanthogranuloma - a systematic review.
    Miguel D; Lukacs J; Illing T; Elsner P
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):221-235. PubMed ID: 27436448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Bilateral vestibulopathy and sensorineural hearing loss in necrobiotic xanthogranuloma, multiple myeloma and amiloidosis].
    Reznik EV; Guseva AL; Yasnovskaya AA; Nguyen TL; Mikhaleva LM; Gioeva ZV; Baybakova EV; Smirnov AP
    Vestn Otorinolaringol; 2024; 89(2):82-87. PubMed ID: 38805468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.